by Premier Pharmacy Labs | Jun 23, 2014 | 503B Outsourcing, Case Studies
In this day and age of higher pharmaceutical scrutiny both in manufacturing and cost; hospitals, clinics, and surgery centers alike are finding more ways to justify outsourcing their sterile pharmacy needs. The advantages of outsourced sterile compounding are three...
by Premier Pharmacy Labs | Jun 5, 2014 | 503B Outsourcing, cGMP
In April of 2014, Premier Pharmacy Labs registered with the FDA as a 503B Outsourcing Facility under the new Drug Quality and Security Act (DQSA). This voluntary registration is made available to large-scale facilities engaged in non-prescription anticipatory...
